Tricyclic Antidepressants: The QT Interval and Other Cardiovascular Parameters

Journal of Child and Adolescent Psychopharmacology

Volumn 1, Issue 3, 1990, Pages 187-189

  Elliott, Glen R ^a   Popper, Charles W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85012443312     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.1990.1.187     Document Type: Article

References (9)

1. Bartels MG. Varley CK, Mitchell J, Stamm SJ: Pediatric cardiovascular effects of imipramine and desipramine. J Am Acad Child Adolesc Psychiatry 30:100–103, 1991
2. Biederman J: Sudden death in children treated with a tricyclic antidepressant: A commentary. Biol Ther Psychiatry Newsletter 14:1–4, 1991
3. Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz JS, Goldblatt A: A double-blind placebo controlled study of desipramine in the treatment of ADD: II. Serum drug levels and cardiovascular findings. J Am Acad Child Adolesc Psychiatry 28:903–911, 1989
4. Glassman AH, Pardell R, Woodring S: Cardiovascular effects of the standard tricyclic antidepressants. Clin Chem 34:856–858, 1988
5. Jackson WK. Roose SP, Glassman AH: Cardiovascular toxicity and tricyclic antidepressants. Biomed Pharmacother 41:377–382. 1987
6. Popper CW. Elliott GR: Sudden death and tricyclic antidepressants: clinical considerations for children. J Child Adolesc Psychopharmacol 1:125–132, 1990
7. Riddle MA, Nelson JC, Kleinman CS, Rasmusson A, Leckman JF, King RA, Cohen DJ: Sudden death in children receiving Norpramin: A review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 30:104–108, 1991
8. Ryan ND: Heterocyclic antidepressants in children and adolescents. J Child Adolesc Psychopharmacol 1:21–31, 1990
9. Schroeder JS. Mullin AV. Elliott GR. Steiner H, Nichols M, Gordon A, Paulos M: Cardiovascular effects of desipramine in children. J Am Acad Child Adolesc Psychiatry 28:376–379, 1989